14-day Premium Trial Subscription Try For FreeTry Free

Fulgent Genetics (FLGT) to Post Q4 Earnings: What's in Store?

03:37pm, Monday, 21'st Feb 2022 Zacks Investment Research
In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.
In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front, the Food and Drug A

Are These Medical Stocks a Great Value Stocks Right Now?

02:40pm, Thursday, 17'th Feb 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Fullgent Genetics (FLGT) Stock Sinks As Market Gains: What You Should Know

10:45pm, Wednesday, 16'th Feb 2022 Zacks Investment Research
In the latest trading session, Fullgent Genetics (FLGT) closed at $65.84, marking a -0.98% move from the previous day.
In the latest trading session, Fullgent Genetics (FLGT) closed at $65.84, marking a -0.98% move from the previous day.

4 Best Stocks With High Net Income Ratio to Grab Today

12:28pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
OPBK, BBW, EVRI, and FLGT qualified the screen for stocks with a high net income ratio.
OPBK, BBW, EVRI, and FLGT qualified the screen for stocks with a high net income ratio.

Big Tech's Big Returns and Sports Business in the Spotlight

11:45pm, Monday, 14'th Feb 2022 The Motley Fool
Apple posts record revenue. Microsoft makes its intentions clear with respect to its gaming division.
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology-based genetic testing company focused on transforming patient ca
Fulgent Genetics Inc. (NASDAQ:FLGT)s traded shares stood at 0.3 million during the last session, with the companys beta value hitting 1.57. At the close of trading, the stocks price was $70.28, to imply a decrease of -1.71% or -$1.22 in intraday trading. The FLGT shares 52-week high remains $185.50, putting it -163.94% down since that Boom Or Bust: What Does The Future Hold For Fulgent Genetics Inc. (NASDAQ: FLGT) Stock? Read More »

Fullgent Genetics (FLGT) Gains As Market Dips: What You Should Know

10:45pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Fullgent Genetics (FLGT) closed the most recent trading day at $71.50, moving +0.14% from the previous trading session.
Fullgent Genetics (FLGT) closed the most recent trading day at $71.50, moving +0.14% from the previous trading session.

This Sector is 13% of the Stock Market and Has Lifelong Potential

04:53pm, Thursday, 10'th Feb 2022 The Motley Fool
There are a few different ways to invest in this sector, but will it be a winner in 2022?

The Most Important Chart for Fulgent Genetics Shareholders

01:22pm, Thursday, 10'th Feb 2022 The Motley Fool
The die may have already been cast for another blowout quarter.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE